APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefdinir Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cefdinir Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchCefdinir Capsules Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefdinir Capsules Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Cefdinir Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefdinir Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefdinir Capsules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cefdinir Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cefdinir Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cefdinir Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cefdinir Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cefdinir Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cefdinir Capsules include Chengdu Beite Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Hainan Rizhongtian Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Shenzhen Lijian Pharmaceutical Co., Ltd., Shijiazhuang Siyao Co., Ltd., Sichuan Saizhuo Pharmaceutical Co., Ltd., Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. and Zhejiang Jutai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cefdinir Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cefdinir Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cefdinir Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cefdinir Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Cefdinir Capsules Segment by Company

Chengdu Beite Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Hainan Rizhongtian Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Shenzhen Lijian Pharmaceutical Co., Ltd.

Shijiazhuang Siyao Co., Ltd.

Sichuan Saizhuo Pharmaceutical Co., Ltd.

Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.

Zhejiang Jutai Pharmaceutical Co., Ltd.

Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

Cefdinir Capsules Segment by Type

100mg

Other

Cefdinir Capsules Segment by Application

Hospital

Clinic

Other

Cefdinir Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefdinir Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefdinir Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefdinir Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cefdinir Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefdinir Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cefdinir Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cefdinir Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cefdinir Capsules Industry Trends Table 2. Cefdinir Capsules Industry Drivers Table 3. Cefdinir Capsules Industry Opportunities and Challenges Table 4. Cefdinir Capsules Industry Restraints Table 5. Global Cefdinir Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cefdinir Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cefdinir Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cefdinir Capsules Sales Market Share by Manufacturers Table 9. Global Cefdinir Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cefdinir Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cefdinir Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cefdinir Capsules Manufacturers, Product Type & Application Table 13. Global Cefdinir Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cefdinir Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of Other Table 18. Global Cefdinir Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cefdinir Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Cefdinir Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Cefdinir Capsules Sales Market Share by Type (2021-2026) Table 22. Global Cefdinir Capsules Sales Market Share by Type (2027-2032) Table 23. Global Cefdinir Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cefdinir Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Cefdinir Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Cefdinir Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Cefdinir Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Cefdinir Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cefdinir Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Cefdinir Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Cefdinir Capsules Sales Market Share by Application (2021-2026) Table 35. Global Cefdinir Capsules Sales Market Share by Application (2027-2032) Table 36. Global Cefdinir Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cefdinir Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Cefdinir Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Cefdinir Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Cefdinir Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Cefdinir Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cefdinir Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Cefdinir Capsules Sales Market Share by Region (2021-2026) Table 44. Global Cefdinir Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cefdinir Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cefdinir Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cefdinir Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Cefdinir Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cefdinir Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cefdinir Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cefdinir Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Cefdinir Capsules Revenue Market Share by Region (2027-2032) Table 63. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 64. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 65. Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 67. Chengdu Beite Pharmaceutical Co., Ltd. Recent Development Table 68. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 69. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 70. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 72. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 73. Hainan Rizhongtian Pharmaceutical Co., Ltd. Company Information Table 74. Hainan Rizhongtian Pharmaceutical Co., Ltd. Business Overview Table 75. Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 77. Hainan Rizhongtian Pharmaceutical Co., Ltd. Recent Development Table 78. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 79. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 80. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Product Portfolio Table 82. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 83. Shenzhen Lijian Pharmaceutical Co., Ltd. Company Information Table 84. Shenzhen Lijian Pharmaceutical Co., Ltd. Business Overview Table 85. Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 87. Shenzhen Lijian Pharmaceutical Co., Ltd. Recent Development Table 88. Shijiazhuang Siyao Co., Ltd. Company Information Table 89. Shijiazhuang Siyao Co., Ltd. Business Overview Table 90. Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Product Portfolio Table 92. Shijiazhuang Siyao Co., Ltd. Recent Development Table 93. Sichuan Saizhuo Pharmaceutical Co., Ltd. Company Information Table 94. Sichuan Saizhuo Pharmaceutical Co., Ltd. Business Overview Table 95. Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 97. Sichuan Saizhuo Pharmaceutical Co., Ltd. Recent Development Table 98. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Company Information Table 99. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Business Overview Table 100. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 102. Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Recent Development Table 103. Zhejiang Jutai Pharmaceutical Co., Ltd. Company Information Table 104. Zhejiang Jutai Pharmaceutical Co., Ltd. Business Overview Table 105. Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 107. Zhejiang Jutai Pharmaceutical Co., Ltd. Recent Development Table 108. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information Table 109. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Business Overview Table 110. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio Table 112. Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Cefdinir Capsules Distributors List Table 116. Cefdinir Capsules Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Cefdinir Capsules Product Image Figure 2. Global Cefdinir Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefdinir Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefdinir Capsules Sales (2021-2032) & (K Units) Figure 5. Global Cefdinir Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cefdinir Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. Other Image Figure 10. Global Cefdinir Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cefdinir Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cefdinir Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Cefdinir Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cefdinir Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cefdinir Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Cefdinir Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cefdinir Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cefdinir Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Cefdinir Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cefdinir Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cefdinir Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 39. China Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cefdinir Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cefdinir Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cefdinir Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cefdinir Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cefdinir Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cefdinir Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cefdinir Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cefdinir Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cefdinir Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cefdinir Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chengdu Beite Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Hainan Rizhongtian Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Shenzhen Lijian Pharmaceutical Co., Ltd.
  • Shijiazhuang Siyao Co., Ltd.
  • Sichuan Saizhuo Pharmaceutical Co., Ltd.
  • Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.
  • Zhejiang Jutai Pharmaceutical Co., Ltd.
  • Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cefdinir Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cefdinir Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cefdinir Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cefdinir Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cefdinir Capsules Market Dynamics
  1. 2.1 Cefdinir Capsules Industry Trends
  2. 2.2 Cefdinir Capsules Industry Drivers
  3. 2.3 Cefdinir Capsules Industry Opportunities and Challenges
  4. 2.4 Cefdinir Capsules Industry Restraints
3 Cefdinir Capsules Market by Manufacturers
  1. 3.1 Global Cefdinir Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cefdinir Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cefdinir Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cefdinir Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefdinir Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cefdinir Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Cefdinir Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefdinir Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefdinir Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefdinir Capsules Tier 1, Tier 2, and Tier 3
4 Cefdinir Capsules Market by Type
  1. 4.1 Cefdinir Capsules Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 Other
  4. 4.2 Global Cefdinir Capsules Sales by Type
  5. 4.2.1 Global Cefdinir Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cefdinir Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Cefdinir Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cefdinir Capsules Revenue by Type
  9. 4.3.1 Global Cefdinir Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cefdinir Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Cefdinir Capsules Revenue Market Share by Type (2021-2032)
5 Cefdinir Capsules Market by Application
  1. 5.1 Cefdinir Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Cefdinir Capsules Sales by Application
  6. 5.2.1 Global Cefdinir Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cefdinir Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Cefdinir Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cefdinir Capsules Revenue by Application
  10. 5.3.1 Global Cefdinir Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cefdinir Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Cefdinir Capsules Revenue Market Share by Application (2021-2032)
6 Global Cefdinir Capsules Sales by Region
  1. 6.1 Global Cefdinir Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cefdinir Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Cefdinir Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Cefdinir Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cefdinir Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cefdinir Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cefdinir Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cefdinir Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cefdinir Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cefdinir Capsules Revenue by Region
  1. 7.1 Global Cefdinir Capsules Revenue by Region
  2. 7.1.1 Global Cefdinir Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cefdinir Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Cefdinir Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Cefdinir Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cefdinir Capsules Revenue (2021-2032)
  8. 7.2.2 North America Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cefdinir Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cefdinir Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cefdinir Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cefdinir Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu Beite Pharmaceutical Co., Ltd.
  2. 8.1.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu Beite Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  6. 8.1.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  8. 8.2.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  12. 8.2.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Hainan Rizhongtian Pharmaceutical Co., Ltd.
  14. 8.3.1 Hainan Rizhongtian Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Hainan Rizhongtian Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Rizhongtian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  18. 8.3.5 Hainan Rizhongtian Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Cefdinir Capsules Product Portfolio
  24. 8.4.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Shenzhen Lijian Pharmaceutical Co., Ltd.
  26. 8.5.1 Shenzhen Lijian Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shenzhen Lijian Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shenzhen Lijian Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  30. 8.5.5 Shenzhen Lijian Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shijiazhuang Siyao Co., Ltd.
  32. 8.6.1 Shijiazhuang Siyao Co., Ltd. Company Information
  33. 8.6.2 Shijiazhuang Siyao Co., Ltd. Business Overview
  34. 8.6.3 Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shijiazhuang Siyao Co., Ltd. Cefdinir Capsules Product Portfolio
  36. 8.6.5 Shijiazhuang Siyao Co., Ltd. Recent Developments
  37. 8.7 Sichuan Saizhuo Pharmaceutical Co., Ltd.
  38. 8.7.1 Sichuan Saizhuo Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Sichuan Saizhuo Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sichuan Saizhuo Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  42. 8.7.5 Sichuan Saizhuo Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd.
  44. 8.8.1 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  48. 8.8.5 Tianjin Pharmaceutical Group Jinkang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Zhejiang Jutai Pharmaceutical Co., Ltd.
  50. 8.9.1 Zhejiang Jutai Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Zhejiang Jutai Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Jutai Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  54. 8.9.5 Zhejiang Jutai Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
  56. 8.10.1 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Cefdinir Capsules Product Portfolio
  60. 8.10.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cefdinir Capsules Value Chain Analysis
  2. 9.1.1 Cefdinir Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cefdinir Capsules Production Mode & Process
  6. 9.2 Cefdinir Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cefdinir Capsules Distributors
  9. 9.2.3 Cefdinir Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst